. Author manuscript; available in PMC: 2014 Dec 1.

Published in final edited form as: J Adolesc Health. 2013 Aug 21;53(6):10.1016/j.jadohealth.2013.07.006. doi: 10.1016/j.jadohealth.2013.07.006

Table 5.

Summary of final regression models for association of HIV disease measures with neurocognitive outcomes

	CD4 count¹				log₁₀ viral load				Years since first positive HIV test²

	Regression		Upper		Regression				Regression
Outcome	effect/odds	Lower	95%		effect/odds	Lower	Upper		effect/odds	Lower	Upper
variables	ratio³	95% CI	CI	p-value	ratio³	95% CI	95% CI	p-value	ratio³	95% CI	95% CI	p-value
Global
Functioning	0.339	−0.076	0.755	0.109	0.801	−0.616	2.218	0.266	−0.644	−1.252	−0.037	0.038
Attention Scale	0.002	−0.045	0.049	0.927	−0.046	−0.205	0.114	0.574	−0.038	−0.108	0.031	0.278
Motor Scale	0.020	−0.037	0.078	0.482	−0.004	−0.204	0.196	0.966	−0.031	−0.122	0.060	0.504
Executive Scale	0.063	0.015	0.110	0.010	0.141	−0.022	0.304	0.089	−0.059	−0.128	0.010	0.096
Memory Scale	0.040	−0.023	0.103	0.209	0.046	−0.166	0.259	0.668	−0.029	−0.121	0.062	0.527
Mean z-score	0.029	−0.011	0.070	0.150	0.056	−0.083	0.194	0.428	−0.036	−0.096	0.024	0.244
HAND	0.820	0.708	0.950	0.008	0.701	0.430	1.145	0.156	0.988	0.792	1.231	0.912

Model for CD4 count shows change per 100 cell increase.

Models for duration of HIV show change per one year increase in duration.

Models adjusted for race/ethnicity, education level, gender, income, concomitant medications that might affect performance, alcohol use severity index, Brief Symptom Inventory, diagnoses potentially affecting performance, and education risk (special classes/repeated year). See Results for further details.